Opportunity ID: 331591

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-FD-21-017
Funding Opportunity Title: Renewal : UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (U01) Clinical Trials Optional
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Consumer Protection
Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.103 — Food and Drug Administration Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Feb 18, 2021
Last Updated Date: Feb 18, 2021
Original Closing Date for Applications: May 25, 2021
Current Closing Date for Applications: May 25, 2021
Archive Date: Jun 24, 2021
Estimated Total Program Funding:
Award Ceiling: $16,000,000
Award Floor: $1,000,000

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Eligible Organizations

Eligibility is limited to the Center of Excellence in Regulatory Science and Innovation (CERSI) at:

University of California, San Francisco

Additional Information

Agency Name: Food and Drug Administration
Description:

As part of FDA’s Advancing Regulatory Science Initiative, the Office of the Chief Scientist supports innovation aimed at development of new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products.

This funding opportunity will provide support, depending on availability of FDA funding, for the existing Center of Excellence in Regulatory Science and Innovation (CERSI) at University of California, San Francisco-Stanford University. This CERSI will serve to advance the Agency’s regulatory science goals predominantly through cutting-edge collaborative research with FDA; they may also provide training in regulatory science.

Link to Additional Information: RFA-FD-21-017 – Full Announcement
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Shashi Malhotra

Grants Management Specialist

Phone 2404027592
Email:shashi.malhotra@fda.hhs.gov

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: Shashi Malhotra
Grants Management Specialist
Phone 2404027592
Email: shashi.malhotra@fda.hhs.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.103 RFA-FD-21-017 FORMS F PKG00265533 Feb 18, 2021 May 25, 2021 View

Package 1

Mandatory forms

331591 RR_SF424_2_0-2.0.pdf

331591 PHS398_CoverPageSupplement_4_0-4.0.pdf

331591 RR_OtherProjectInfo_1_4-1.4.pdf

331591 PerformanceSite_2_0-2.0.pdf

331591 RR_KeyPersonExpanded_2_0-2.0.pdf

331591 RR_Budget_1_4-1.4.pdf

331591 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

331591 RR_SubawardBudget30_1_4-1.4.pdf

331591 PHS_AssignmentRequestForm_2_0-2.0.pdf

2025-07-11T06:37:09-05:00

Share This Post, Choose Your Platform!

About the Author: